Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Hepatitis G virus infections in Iceland

Love, A ; Stanzeit, B ; Gudmundsson, S and Widell, Anders LU (1999) In Journal of Viral Hepatitis 6(3). p.255-260
Abstract
This study describes the prevalence of hepatitisG virus (HGV) in Iceland, in blood donors and in persons with parenteral risk factors. Among 370 randomly selected Icelandic blood donors, the prevalence of HGV viraemia was 3.8%, whereas the prevalence of HGV antibodies in the same donor group was found to be 13.2%, thus indicating that at least 17% of blood donors in Iceland had previously been exposed to HGV. Previous exposure was seen in all age groups and also in older blood donors. Among intravenous drug users (IVDUs), the prevalence of HGV was much higher. Among 109 hepatitisC virus (HCV) antibody-positive serum samples collected in the years 1992-1997, 33. 9% were polymerase chain reaction (PCR)-positive for HGV and 48.6% had HGV... (More)
This study describes the prevalence of hepatitisG virus (HGV) in Iceland, in blood donors and in persons with parenteral risk factors. Among 370 randomly selected Icelandic blood donors, the prevalence of HGV viraemia was 3.8%, whereas the prevalence of HGV antibodies in the same donor group was found to be 13.2%, thus indicating that at least 17% of blood donors in Iceland had previously been exposed to HGV. Previous exposure was seen in all age groups and also in older blood donors. Among intravenous drug users (IVDUs), the prevalence of HGV was much higher. Among 109 hepatitisC virus (HCV) antibody-positive serum samples collected in the years 1992-1997, 33. 9% were polymerase chain reaction (PCR)-positive for HGV and 48.6% had HGV antibodies. Thus, the pattern of HGV in IVDUs was similar to findings among IVDUs in other western countries. HGV viraemia was detected neither in 10 patients with haemophilia nor in five dialysis patients. However, six of the 10 haemophilic patients and one of the five dialysis patients had HGV antibody. In conclusion, unlike hepatitis C, which seems to have been introduced into Iceland relatively recently and has remained virtually confined to IVDUs, exposure to HGV is common among all age groups in the general population, suggesting that the virus has been prevalent in Iceland for much longer, making additional routes of transmission probable. (Less)
Please use this url to cite or link to this publication:
author
; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
epidemiology, GB virus C, hepatitis G, hepatitis non-A, hepatitis non-E, Iceland, prevalence
in
Journal of Viral Hepatitis
volume
6
issue
3
pages
255 - 260
publisher
Wiley-Blackwell
external identifiers
  • pmid:10607239
  • scopus:0032977217
ISSN
1365-2893
DOI
10.1046/j.1365-2893.1999.00143.x
language
English
LU publication?
yes
id
386165b2-8f0b-4b9c-a8e6-7617f1c7f81d (old id 1114244)
date added to LUP
2016-04-01 11:42:31
date last changed
2022-03-05 05:19:22
@article{386165b2-8f0b-4b9c-a8e6-7617f1c7f81d,
  abstract     = {{This study describes the prevalence of hepatitisG virus (HGV) in Iceland, in blood donors and in persons with parenteral risk factors. Among 370 randomly selected Icelandic blood donors, the prevalence of HGV viraemia was 3.8%, whereas the prevalence of HGV antibodies in the same donor group was found to be 13.2%, thus indicating that at least 17% of blood donors in Iceland had previously been exposed to HGV. Previous exposure was seen in all age groups and also in older blood donors. Among intravenous drug users (IVDUs), the prevalence of HGV was much higher. Among 109 hepatitisC virus (HCV) antibody-positive serum samples collected in the years 1992-1997, 33. 9% were polymerase chain reaction (PCR)-positive for HGV and 48.6% had HGV antibodies. Thus, the pattern of HGV in IVDUs was similar to findings among IVDUs in other western countries. HGV viraemia was detected neither in 10 patients with haemophilia nor in five dialysis patients. However, six of the 10 haemophilic patients and one of the five dialysis patients had HGV antibody. In conclusion, unlike hepatitis C, which seems to have been introduced into Iceland relatively recently and has remained virtually confined to IVDUs, exposure to HGV is common among all age groups in the general population, suggesting that the virus has been prevalent in Iceland for much longer, making additional routes of transmission probable.}},
  author       = {{Love, A and Stanzeit, B and Gudmundsson, S and Widell, Anders}},
  issn         = {{1365-2893}},
  keywords     = {{epidemiology; GB virus C; hepatitis G; hepatitis non-A; hepatitis non-E; Iceland; prevalence}},
  language     = {{eng}},
  number       = {{3}},
  pages        = {{255--260}},
  publisher    = {{Wiley-Blackwell}},
  series       = {{Journal of Viral Hepatitis}},
  title        = {{Hepatitis G virus infections in Iceland}},
  url          = {{http://dx.doi.org/10.1046/j.1365-2893.1999.00143.x}},
  doi          = {{10.1046/j.1365-2893.1999.00143.x}},
  volume       = {{6}},
  year         = {{1999}},
}